DKICP is well represented at ASHP Midyear Meeting

DKICP had 17 students present research posters at the recent American Society of Health-Systems Pharmacists (ASHP) Midyear Clinical Meeting and Exhibition, held December 4-7, 2022, in Las Vegas.

As the largest annual professional meeting for pharmacists representing hospitals and health systems across the country, involvement of these students included them among the highest contributors from colleges and schools of pharmacy nationwide.

Following is a list of participating students, along with their poster category and title:

Earl Jon Emboltura – Drug information/Drug use evaluation – Medicare prescribing trends of Canagliflozin and Empagliflozin nationally and in Hawaiʻi from 2013-2020

Kailani Timmons – Safety/Quality – Medicare prescribing trends of statins, fibrates and omega-3 fatty acids from 2013-2020

Skye Pyo – Infectious disease/HIV – Comparison of antibiotic prescribing trends and Clostridioides difficile infections rates in the U.S. from 2013-2020

Rosalie White – Drug information/Drug use evaluation – An analysis of FDA-approved drugs from 2018-2022

May Ann Vicente (Hudgins) – Geriatrics – Prevalence of potentially inappropriate medications for older adults on cardiovascular and endocrine drugs in a family medicine clinic

Ronel Jordan Quebral – Cardiology/Anticoagulation – Comparison of Furosemide prescribing and heart failure hospitalizations by state from 2017-2019

Brennan Palani Buccat – Chronic/Managed care – Comparative health behavioral analysis between Filipino adults and Caucasian adults in Hawaiʻi with association to diabetes, overweight and obesity prevalence

Chrystal Cardoza – Toxicology – Examining Naloxone distribution in accordance with prescription opioid-related deaths

Ann-Janin Bacani – Geriatrics – Evaluation of potentially inappropriate nonbenzodiazepine receptor agonist hypnotics prescribing among elderly Medicare patients by prescriber type in the U.S. and Hawaiʻi

Katrina Heyer – Ambulatory care – 2020 heart disease deaths compared to Medicare proprotein convertase subtilisin/kexin type 9 serine protease inhibitor prescription rates

Daijiro Oshitari – Safety/Quality – COVID-19 vaccines impact on 2021 coronavirus disease 2019 (COVID-19) related deaths versus hospitalization by state

Olatunji Gbadebo – Ambulatory care – Examining prevention quality indicators, cost and length of stay for diabetes across counties in Hawaiʻi

Debra Towell – Ambulatory care – Obesity and diabetes correlation and the pharmacist’s role in diabetes prevention programs

Kateleen Caye Bio – Ambulatory care – Evaluation of lipid-lowering regimens in patients with diabetes mellitus

Analeslie Martinez – Ambulatory care – Comparison of Medicare statin prescribing and stroke deaths in the U.S. from 2017-2019

Stephanie Mojumdar – Transplant/Immunology – Possible Azathioprine-induced posterior reversible encephalopathy syndrome during the management of acute exacerbation of systemic lupus erythematosus

Matthew Neumann – Ambulatory care – Assessing the use of insulin and glucagon-like peptide-1 receptor agonists in patients with type-2 diabetes mellitus in a primary care clinic